Home › Health › Pharmacist issues 'ask your GP' Mounjaro warning to...
Health

Pharmacist issues 'ask your GP' Mounjaro warning to parents of teenagers

Pharmacist issues 'ask your GP' Mounjaro warning to parents of teenagers
Key Points

Pharmacist issues 'ask your GP' Mounjaro warning to parents of teenagers A new study has put the weight-loss injection in the spotlight, but a TikTok pharmacist says there is more parents need to understand Weight-loss medication continues to create plenty of discussion, but now its potential use among children and young people is under the spotlight. Pharmacist Raj Patel, known as the Straight Talking Pharmacist to his more than 100,000 followers on TikTok, has issued a warning to parents...

Pharmacist issues 'ask your GP' Mounjaro warning to parents of teenagers A new study has put the weight-loss injection in the spotlight, but a TikTok pharmacist says there is more parents need to understand Weight-loss medication continues to create plenty of discussion, but now its potential use among children and young people is under the spotlight. Pharmacist Raj Patel, known as the Straight Talking Pharmacist to his more than 100,000 followers on TikTok, has issued a warning to parents about what the latest research means for their teenagers. The medical professional turned content creator discussed a clinical trial involving teenagers with obesity, as well as some young people who were overweight and had a related health problem. The study examined tirzepatide, the active ingredient in Mounjaro, alongside support with diet and physical activity. Published in JAMA in November, the Lilly-funded trial followed 160 young people for 72 weeks. Researchers found average BMI fell by 18.5 per cent among those receiving tirzepatide, compared with a 0.5 per cent increase in the placebo group. BMI is a measurement based on a person's weight in relation to their height, and a percentage change in BMI should not be confused with the same percentage change in body weight. The trial also found that 10 of the 108 participants who received tirzepatide stopped treatment because of adverse effects, equivalent to around one in 11. There is also an important distinction between the trial results and what is currently authorised in the UK. Mounjaro is licensed for treating type 2 diabetes in children and teenagers aged 10 and over, but its product information says its safety and effectiveness for weight management have not been established in people under 18. Ensure our latest Health headlines always appear at the top of your Google Search by making us a Preferred Source. Click here to activate or add us as Preferred Source in your Google search settings Mr Patel warned parents against assuming the research means the injection is now an approved weight-loss option for teenagers: "Mounjaro isn't licenced in the UK for weight management under 18 year olds and the trial result is not the same as a new licence." The NHS advises parents who are concerned about a child's weight to speak to their GP, school nurse or practice nurse, who can offer support with diet and lifestyle changes. The pharmacist also urged families to seek professional advice rather than sharing medication, saying: "And if you're worried about your teenager's weight ask your GP what is available and please don't ever share injections." The trial provides new evidence about tirzepatide in adolescents, but it does not change the current UK position on its use for weight management in under-18s.
GP (ORG) Mounjaro (ORG) Pharmacist (ORG) TikTok (ORG) Raj Patel (PERSON) tirzepatide (ORG) JAMA (ORG) Lilly (ORG) BMI (ORG) UK (LOCATION) Preferred Source (ORG) Google (ORG) Patel (PERSON) NHS (ORG)
Originally published by Daily Mirror Read original →